Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Category 2 (significant safety risks) for compounding
Injections come with risks
Pffflin A, Schleicher E (2009) Inflammation markers in point-of-care testing (POCT)
Helps fade dark spots and uneven tone
After opening, do not store the product for more than 2 months
It typically presents as macrocytic megaloblastic anemia and neurological impairments, including sensory and motor disfunctions, predominantly in the lower extremities, ataxia, and in more advanced stages cognitive decline progressing to dementia, as well as psychiatric disturbances ( Subclinical B12 deficiency, however, is far more prevalent, affecting up to 26% of the general population
US$ 28.12
US$ 26.93
US$ 22.97
US$ 29.72
US$ 28.98
US$ 28.40
